Otsuka launches English website for global viewers

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

Singapore: Japan-based Otsuka Pharmaceutical launched a newly designed English corporate website in collaboration with an Amsterdam-based creative agency. The new site reflects Otsuka's phi...Read more

Takeda diabetes drug gets China's import license

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

Singapore: China's State Food and Drug Administration (SFDA) issued an Import Drug License (IDL) for Takeda's type 2 diabetes drug Nesina (alogliptin). Orally administered dipeptidyl pept...Read more

Japan Minister: Dont be afraid of new science strategy

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

Singapore: Japanese scientists are skeptical about the country's new strategy for economic growth, which includes an emphasis on applied biomedical research. Several life science organizati...Read more

Takeda appoints first-ever non-Japanese president

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Dec, 2013

Singapore: In an effort to speedup business expansion in emerging nations, Japan's largest drug maker, Takeda Pharmaceuticals has chosen its new president from a rival company. The company...Read more

FDA panel approves new obesity drug, Eisai to market it

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2012

Cambridge, Massachusetts: Lorcaserin, a chemical drug that aims to control obesity by altering the serotonin receptors in the brain that control hunger pangs, developed by Arena Pharmaceuti...Read more

Japan pharma to grow at 2% CAGR from 2013-20

Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2013

Singapore: Simplification of the regulatory process will prove to be the key to the growth of the pharma market in Japan, claimed a recent report by Research and Markets. The CountryFocus ...Read more

APAC healthcare industry becomes cloud friendly

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 Nov, 2013

Singapore: A recent report presented by Frost & Sullivan has said that the healthcare industry in Asia Pacific is embracing the full gamut of cloud provided services from infrastructure...Read more

Eisai signs agreement with Epizyme and Roche

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

Singapore: Eisai has signed an agreement with Epizyme and Roche Molecular Systems to collaborate on the development of a companion diagnostic to help Eisai and Epizyme identify patients fo...Read more

Takeda, Lundbeck to present depression study data

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 20 May, 2013

Singapore: Takeda Pharmaceutical and H Lundbeck will be presenting new data from four studies that evaluated effectiveness in treating the overall symptoms of depression in patients taking ...Read more

Japan Vaccine begins operation

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jul, 2012

Singapore: Japan Vaccine, a joint venture created by equal investments from Daiichi Sankyo and GlaxoSmithKline, started its operation from July 3, 2012. Japan Vaccine will hold all develop...Read more

Japan approves generic drug for osteoporosis

Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 28 Dec, 2012

Singapore: Actonel 75 mg tablets and Benet 75 mg tablets, a once-monthly formulation of risedronate sodium hydrate (generic name) for the treatment of osteoporosis by Ajinomoto Pharmaceutic...Read more

Mitsubishi proton system aids cancer therapy in Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2013

Singapore: Mitsubishi Electric to supply its proton beam therapy system for cancer treatment to Tsuyama Chuo Hospital, Japan, led by Mr Yoshinori Ukita, president of Tsuyama Jifu Group, in ...Read more

Japan approves reimbursement for Edwards' Sapien XT valve

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2013

Singapore: Edwards Lifesciences, makers of heart valves and hemodynamic monitoring, has announced that Japan's Central Social Insurance Medical Council (Chuikyo) has approved the recommenda...Read more

MTPC completes acquisition of Medicago

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Sep, 2013

Singapore: Japanese drugmaker Mitsubishi Tanabe Pharma Corporation (MTPC) and Canada-based Medicago, a clinical-stage biopharmaceutical company developing novel vaccines and therapeutic pro...Read more

Bionest and Scisive merge together

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 31 Dec, 2012

Singapore: Bionest Partners and Scisive Consulting have merged to form a global strategy and management consulting firms for the life science industries. The merged companies will operate u...Read more

Shionogi launches London headquarter

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jul, 2012

Singapore: Japan-based pharmaceutical company Shionogi has launched its new European Headquarters in London, UK, to be called Shionogi Limited. The new headquarters will form a new era for ...Read more

A time to rethink talent management

Japan |  Opinion | By BioSpectrum Bureau  | 0 Comment | 29 May, 2012

        Year 2011 was an action-packed-year for HR professionals in Asia Pacific life sciences industry. It tested their skills to keep pace with the high level of investment and ...Read more

Astellas, Merck enter co-promotion deal in Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2013

Singapore: Astellas Pharma and MSD KK, the Japan unit of US pharma giant Merck, have entered into a co-promotion agreement for ipragliflozin L-proline, a SGLT2 inhibitor, in Japan. Earlier ...Read more